Clinical trials

  • MIGALASTAT HYDROCHLORIDE for Fabry disease
  • Obinutuzumab for Primary membranous nephropathy
  • IAM1363 for HER2-altered relapsed/refractory malignancy | HER2 gene amplification
  • RILUZOLE for Spinocerebellar ataxia type 7
  • LINEZOLID for Staphylococcus aureus bacteremia
  • FLUOROETHYLTYROSINE F-18 for ACTH-dependent hypercortisolism | Cushing's disease
  • LY4057996 for Type 1 diabetes | Type 2 diabetes | Healthy volunteer
  • SEMAGLUTIDE for Infertility
  • HYDROCORTISONE PH. EUR. for Adrenal hyperplasia | Primary adrenal insufficiency | Panhypopituitarism (secondary or tertiary adrenal insufficiency)
  • LAVENDER OIL for Major depressive disorder (mild to moderate) | Major depression
  • Temozolomide for Glioblastoma
  • VISUGROMAB for Hepatocellular carcinoma (unresectable or metastatic) | Compensated liver disease (Child-Pugh A)